Abstract Submission for #BOPA2026 opens 30th March 2026

Abstract Submission for the 29th Annual BOPA Conference 2026 opens on 30th March 2026

 

 

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by midnight on Monday 22nd June 2026. Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

 

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal.

 

Prizes:

• 1st Prize Oral Plenary: £1500 (to attend an international conference or pay towards research funding including open access publishing fees).
• 2nd Prize Oral Plenary: £500.

• All Oral Plenary presenters: free registration for BOPA 2027.
• All “Highly Recommended” presenters: free BOPA membership for 2027.
• The three best poster winners: free BOPA membership for 2027.

 

Click here for Call for Abstracts printable PDF

Click here for Abstract Marking Scheme as printable PDF 

 

Click here to go to the Abstract Submission Page

(Submission opens 30th March 2026)

 

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article